Fractyl Health, Inc. (GUTS)
(Delayed Data from NSDQ)
$2.79 USD
-0.07 (-2.45%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $2.78 -0.01 (-0.36%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for Fractyl Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 34 | 49 | -99,999 | -99,999 | -99,999 |
Receivables | 0 | 0 | NA | NA | NA |
Notes Receivable | 0 | 0 | NA | NA | NA |
Inventories | 0 | 0 | NA | NA | NA |
Other Current Assets | 2 | 2 | NA | NA | NA |
Total Current Assets | 36 | 52 | NA | NA | NA |
Net Property & Equipment | 0 | 0 | NA | NA | NA |
Investments & Advances | 0 | 0 | NA | NA | NA |
Other Non-Current Assets | 0 | 0 | NA | NA | NA |
Deferred Charges | 0 | 0 | NA | NA | NA |
Intangibles | 0 | 0 | NA | NA | NA |
Deposits & Other Assets | 10 | 8 | NA | NA | NA |
Total Assets | 76 | 61 | NA | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | NA |
Accounts Payable | 1 | 1 | NA | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | NA |
Current Portion Capital Leases | 0 | 0 | NA | NA | NA |
Accrued Expenses | 7 | 5 | NA | NA | NA |
Income Taxes Payable | 0 | 0 | NA | NA | NA |
Other Current Liabilities | 1 | 0 | NA | NA | NA |
Total Current Liabilities | 11 | 7 | NA | NA | NA |
Mortgages | 0 | 0 | NA | NA | NA |
Deferred Taxes/Income | 0 | 0 | NA | NA | NA |
Convertible Debt | 0 | 0 | NA | NA | NA |
Long-Term Debt | 55 | 18 | NA | NA | NA |
Non-Current Capital Leases | 0 | 0 | NA | NA | NA |
Other Non-Current Liabilities | 306 | 288 | NA | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | NA |
Total Liabilities | 401 | 313 | NA | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | NA |
Common Stock (Par) | 0 | 0 | NA | NA | NA |
Capital Surplus | 22 | 17 | NA | NA | NA |
Retained Earnings | -347 | -270 | NA | NA | NA |
Other Equity | 0 | 0 | NA | NA | NA |
Treasury Stock | 0 | 0 | NA | NA | NA |
Total Shareholder's Equity | -325 | -252 | NA | NA | NA |
Total Liabilities & Shareholder's Equity | 76 | 61 | NA | NA | NA |
Total Common Equity | -325 | -252 | 0 | 0 | 0 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Fractyl Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 103 | 122 | 34 | -99,999 | 0 |
Receivables | 0 | 0 | 0 | NA | 0 |
Notes Receivable | 0 | 0 | 0 | NA | 0 |
Inventories | 0 | 0 | 0 | NA | 0 |
Other Current Assets | 4 | 3 | 2 | NA | 0 |
Total Current Assets | 107 | 124 | 36 | NA | 0 |
Net Property & Equipment | 3 | 2 | 0 | NA | 0 |
Investments & Advances | 0 | 0 | 0 | NA | 0 |
Other Non-Current Assets | 0 | 0 | 0 | NA | 0 |
Deferred Charges | 0 | 0 | 0 | NA | 0 |
Intangibles | 0 | 0 | 0 | NA | 0 |
Deposits & Other Assets | 8 | 8 | 10 | NA | 0 |
Total Assets | 146 | 164 | 76 | NA | 0 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | NA | 0 |
Accounts Payable | 2 | 1 | 1 | NA | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | NA | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | NA | 0 |
Accrued Expenses | 7 | 9 | 7 | NA | 0 |
Income Taxes Payable | 0 | 0 | 0 | NA | 0 |
Other Current Liabilities | 0 | 0 | 1 | NA | 0 |
Total Current Liabilities | 14 | 13 | 11 | NA | 0 |
Mortgages | 0 | 0 | 0 | NA | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | NA | 0 |
Convertible Debt | 0 | 0 | 0 | NA | 0 |
Long-Term Debt | 28 | 29 | 55 | NA | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | NA | 0 |
Other Non-Current Liabilities | 5 | 306 | NA | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | NA | 0 |
Total Liabilities | 76 | 79 | 401 | NA | 0 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | NA | 0 |
Common Stock (Par) | 0 | 0 | 0 | NA | 0 |
Capital Surplus | 438 | 434 | 22 | NA | 0 |
Retained Earnings | -367 | -350 | -347 | NA | 0 |
Other Equity | 0 | 0 | 0 | NA | 0 |
Treasury Stock | 0 | 0 | 0 | NA | 0 |
Total Shareholder's Equity | 71 | 84 | -325 | NA | 0 |
Total Liabilities & Shareholder's Equity | 146 | 164 | 76 | NA | 0 |
Total Common Equity | 71 | 84 | -325 | 0 | 0 |
Shares Outstanding | 47.90 | 47.80 | NA | NA | NA |
Book Value Per Share | 1.48 | 1.76 | 0.00 | 0.00 | 0.00 |